Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Drug Design, Development and Therapy|July 13, 2012
Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case seriesTodd LevineJournal of the Neurological Sciences|November 22, 2024
Early deterioration of CIDP following transition from IVIG to FcRn inhibitor treatmentTodd Levine, Suraj MuleyThe Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|July 29, 2011
Clinical recognition and management of amyotrophic lateral sclerosis: the nurse's roleKathie Clarke, Todd LevineJournal of Clinical Neuromuscular Disease|November 26, 2024
Small-Vessel Vasculitis or Perifolliculitis in Small-Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 AntibodiesLawrence A Zeidman, Todd Levine, John CangelosiNeurology and Therapy|July 11, 2026
A Practical Guide to Management of Chronic Inflammatory Demyelinating PolyradiculoneuropathyJohannes Jakobsen, Chafic Karam, Krista Kuitwaard, et al.Advances in Therapy|October 28, 2020
A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating PolyneuropathyJeffrey A Allen, Lisa Butler, Todd Levine, et al.Biomarkers in Medicine|March 10, 2026
The Syn-sleep trial protocol: detection of cutaneous phosphorylated alpha-synuclein in REM sleep behavior disorderSarrah Marcotte, Todd Levine, Roy Freeman, et al.Frontiers in Neurology|April 30, 2026
The Syn-Q study: detection of cutaneous phosphorylated alpha-synuclein in Parkinson's disease progression: a trial protocolJourdan H Parent, Todd Levine, Roy Freeman, et al.Biomarkers in Medicine|June 16, 2025
The Syn-D study: detection of cutaneous phosphorylated alpha-synuclein in mild cognitive impairment a trial protocolChristopher H Gibbons, Douglas Galasko, Daniel Press, et al.Medicine|January 12, 2021
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study")Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, et al.Pageof 4